Vera Therapeutics Announces TRUTAKNA™ (atacicept-vymj) Stabilized eGFR and Prevented Kidney Disease Progression Through Two Years in ORIGIN 3 Final Efficacy Analysis in IgA Nephropathy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Dow, S&P 500 fall, tech steadies to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| Veramark Technologies, Inc. (NASDAQ: VERA) | Delayed: 27.88 -1.17 (4.03%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $29.05 | 52 Week High | $1.18 | |||
| Open | $28.75 | 52 Week Low | $0.36 | |||
| Day High | $29.44 | P/E | 464.67 | |||
| Day Low | $27.46 | EPS | $0.06 | |||
| Volume | 1,221,587 | |||||
